In focus · trending topic

Editas Medicine

62 stories · following the connections

Editas Medicine Initiates Clinical Natural History Study to Evaluate Patients with Leber Congenital Amaurosis Type 10 (LCA10)

By Nasdaq OMXSep 12, 2017, 12:00 PM UTC

Editas Medicine to Participate in Morgan Stanley 15th Annual Global Healthcare Conference

By Nasdaq OMXSep 5, 2017, 12:01 PM UTC

Editas Medicine Announces Second Quarter 2017 Results and Update

By Nasdaq OMXAug 9, 2017, 8:03 PM UTC

Editas Medicine to Host Conference Call Discussing Second Quarter 2017 Corporate Update and Results

By Nasdaq OMXAug 7, 2017, 12:01 PM UTC

Editas Medicine to Participate in Investor Conferences in June

By Nasdaq OMXJun 13, 2017, 12:00 PM UTC

Editas Medicine Names Andrew Hirsch to Board of Directors

By Nasdaq OMXMay 31, 2017, 8:02 PM UTC

Editas Medicine Names Andrew Hirsch to Board of Directors

By Nasdaq OMXMay 31, 2017, 8:02 PM UTC

Editas Medicine Announces First Quarter 2017 Results and Update

By Nasdaq OMXMay 15, 2017, 8:02 PM UTC